Naturex Reports Excellent Sales Growth and Good Operating Performances
date:Apr 02, 2014
e, Group restructuring measures rendered necessary by a more than threefold increase in sales in 4 years contributed to growth in recurring EBITDA that reached 53 million (+3.8%), marginally outpaced by sales (+7.0%). Current operating income came to 35.3 million or 11% of sales.

Net operating income and net income in 2012 were increased by a sizeable insurance payment (6.1 million), following the death of Mr. Jacques Dikansky. Restated to eliminate this item, net operating income rose 9.5%.

B
4/15 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/17 10:52